blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1466594

EP1466594 - Stable pharmaceutical solution formulations for pressurised metered dose inhalers [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.10.2009
Database last updated on 31.08.2024
Most recent event   Tooltip09.10.2009No opposition filed within time limitpublished on 11.11.2009  [2009/46]
Applicant(s)For all designated states
CHIESI FARMACEUTICI S.p.A.
Via Palermo, 26/A
43100 Parma / IT
[N/P]
Former [2004/42]For all designated states
CHIESI FARMACEUTICI S.p.A.
Via Palermo, 26/A
I-43100 Parma / IT
Inventor(s)01 / Lewis, David
Via Palermo, 26/A
43100 Parma / IT
02 / Ganderton, David
Via Palermo, 26/A
43100 Parma / IT
03 / Meakin, Brian
Via Palermo, 26/A
43100 Parma / IT
04 / Brambilla, Gaetano
Via Palermo, 26/A
43100 Parma / IT
05 / Ferraris, Alessandra
Via Palermo, 26/A
43100 Parma / IT
 [2004/42]
Representative(s)Adam, Holger, et al
Kraus & Weisert
Patentanwälte PartGmbB
Thomas-Wimmer-Ring 15
80539 München / DE
[N/P]
Former [2004/42]Adam, Holger, Dr., et al
Kraus & Weisert, Patent- und Rechtsanwälte, Thomas-Wimmer-Ring 15
80539 München / DE
Application number, filing date04011423.318.05.2001
[2004/42]
Priority number, dateWO2000EP0463522.05.2000         Original published format: PCT/EP00/04635
[2004/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1466594
Date:13.10.2004
Language:EN
[2004/42]
Type: A3 Search report 
No.:EP1466594
Date:01.12.2004
[2004/49]
Type: B1 Patent specification 
No.:EP1466594
Date:03.12.2008
Language:EN
[2008/49]
Search report(s)(Supplementary) European search report - dispatched on:EP15.10.2004
ClassificationIPC:A61K9/12, A61K31/4704, A61K31/56, A61K31/57, A61K31/46, A61M15/00, B65D83/14
[2004/42]
CPC:
A61K9/008 (EP,US); A61K9/12 (NO); A61K31/167 (EP,US);
A61K31/439 (EP,US); A61K31/4745 (EP,US); A61K31/5386 (EP,US);
A61K31/56 (NO); A61K31/573 (EP,US); A61K45/06 (EP,US);
A61K9/124 (EP,US); A61P11/00 (EP); A61P11/08 (EP) (-)
C-Set:
A61K31/167, A61K2300/00 (EP,US);
A61K31/439, A61K2300/00 (US,EP);
A61K31/5386, A61K2300/00 (US,EP);
A61K31/573, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/42]
Extension statesAL12.05.2005
LT12.05.2005
LV12.05.2005
MK12.05.2005
RO12.05.2005
SI12.05.2005
TitleGerman:Stabile Arzneimittellösung für Druckdosierinhalatoren[2004/42]
English:Stable pharmaceutical solution formulations for pressurised metered dose inhalers[2004/42]
French:Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression[2004/42]
Examination procedure12.05.2005Examination requested  [2005/29]
13.12.2007Despatch of a communication from the examining division (Time limit: M04)
14.04.2008Reply to a communication from the examining division
12.06.2008Communication of intention to grant the patent
14.10.2008Fee for grant paid
14.10.2008Fee for publishing/printing paid
Parent application(s)   TooltipEP01112230.6  / EP1157689
Opposition(s)04.09.2009No opposition filed within time limit [2009/46]
Fees paidRenewal fee
13.05.2004Renewal fee patent year 03
13.05.2004Renewal fee patent year 04
19.05.2005Renewal fee patent year 05
30.05.2006Renewal fee patent year 06
30.05.2007Renewal fee patent year 07
28.05.2008Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]WO9413263  (JAGER PAUL D [US], et al) [YD] 1-13 * page 4, line 1 - line 5 * * page 6, line 26 - line 30 * * page 8, line 25 - page 9, line 12 *;
 [YD]WO9619198  (ASTRA AB [SE], et al) [YD] 1-13 * page 3, line 26 - page 4, line 23 * * claim 19 *;
 [A]US5874063  (BRIGGNER LARS-ERIK [SE], et al) [A] 1-13* column 1, line 65 - line 67 *;
 [A]WO9936095  (ASTRA PHARMA PROD [GB], et al) [A] 1-13 * page 3, line 16 - line 17 * * page 5, line 11 - line 22 *;
 [YD]WO9965464  (BOEHRINGER INGELHEIM PHARMA [US]) [YD] 1-13 * page 7, line 10 - line 30 *;
 [PXD]WO0030608  (CHIESI FARMA SPA [IT], et al) [PXD] 1-13 * page 7, line 8 - page 9, line 12 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.